DelveInsight's "INBRIJA Market Size, Forecast, and Market Insight Report" highlights the details around INBRIJA, which ...

Iwicki, who is also the Chair of the Board and the Compensation Committee, is stepping down to focus on his role as CEO of Inhibikase Therapeutics, Inc. The company clarified that his departure is not ...

Iwicki, who is also the Chair of the Board and the Compensation Committee, is stepping down to focus on his role as CEO of Inhibikase Therapeutics, Inc. The company clarified that his departure is ...

OMERS ADMINISTRATION Corp bought a new position in shares of Inhibikase Therapeutics, Inc. (NYSE:IKT – Free Report) during the 4th quarter, HoldingsChannel.com reports. The fund bought 54,600 shares ...

Release > Milton Werner, Ph.D., who headed up Inhibikase Therapeutics until recently leaving after 16 years, is now the founder and CEO of newly launched ABLi Therapeutics. Story ...

Advancing IKT-001 into a Late-Stage Clinical Trial Program in Pulmonary Arterial Hypertension BOSTON and ATLANTA, May 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ...